Patents by Inventor Nicolas Spegazzini

Nicolas Spegazzini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10874333
    Abstract: Systems and methods are presented for the diagnosis of middle ear pathological conditions based on spectral signatures. Preferred embodiments provide for detection of one or more analytes from the tympanic membrane. Devices use spectral measurements including spectral imaging to non-invasively identify middle ear pathological conditions including cholesteatoma and acute otitis media by providing real-time information of differentially expressed molecules. Devices and methods can also be used to non-invasively detect and quantify blood analytes from the tympanic membrane.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: December 29, 2020
    Assignees: Massachusetts Institute of Technology, Connecticut Children's Medical Center
    Inventors: Rishikesh Pandey, Nicolas Spegazzini, Luis H. Galindo, Ramachandra Dasari, Tulio Alberto Valdez
  • Publication number: 20170127983
    Abstract: Systems and methods of the present invention provide a calibration model that requires minimal information compared with prior techniques. These systems and methods represent the first generalized approach for combined treatment of spectroscopic measurements of a dynamic, mass-transfer system with the underlying kinetic model of said system. The technique can be applied to non-invasive glucose monitoring or monitoring of chemical reaction dynamics.
    Type: Application
    Filed: November 10, 2016
    Publication date: May 11, 2017
    Inventors: Nicolas Spegazzini, Ishan Barman, Narahara Chari Dingari, Rishikesh Pandey, Jaqueline S. Soares, Ramachandra Dasari
  • Publication number: 20170071509
    Abstract: Systems and methods are presented for the diagnosis of middle ear pathological conditions based on spectral signatures. Preferred embodiments provide for detection of one or more analytes from the tympanic membrane. Devices use spectral measurements including spectral imaging to non-invasively identify middle ear pathological conditions including cholesteatoma and acute otitis media by providing real-time information of differentially expressed molecules. Devices and methods can also be used to non-invasively detect and quantify blood analytes from the tympanic membrane.
    Type: Application
    Filed: September 15, 2016
    Publication date: March 16, 2017
    Inventors: Rishikesh Pandey, Nicolas Spegazzini, Luis H. Galindo, Ramachandra Dasari, Tulio Alherto Valdez